The clinical application value of MR defecography in the diagnosis of pelvic organ prolapse with concomitant stress urinary incontinence
10.3969/j.issn.1002-1671.2024.10.017
- VernacularTitle:MR排粪造影在盆底器官脱垂合并压力性尿失禁诊断中的临床应用价值
- Author:
Min LI
1
;
Sumei WANG
;
Tongtong LIU
;
Xiangnan LI
Author Information
1. 首都医科大学附属北京朝阳医院放射科,北京 100020
- Keywords:
magnetic resonance defecography;
stress urinary incontinence;
pelvic organ prolapse;
magnetic resonance imaging
- From:
Journal of Practical Radiology
2024;40(10):1653-1657
- CountryChina
- Language:Chinese
-
Abstract:
Objective To evaluate the diagnostic efficacy of magnetic resonance defecography(MRD)in moderate or severe pelvic organ prolapse(POP)complicated with stress urinary incontinence(SUI).Methods Patients with grade Ⅱ or above POP were prospectively selected,and divided into POP combined with SUI group and isolated POP group.The MRD parameters of pelvic dysfunction between groups were analyzed to clarify the clinical diagnostic value and to evaluate the diagnostic efficacy of MRD in POP combined with SUI.Results This study enrolled 99 POP patients,42 patients in isolated POP group,and 57 patients in POP combined with SUI group.The comparison between groups showed there were significant differences in the function of the urethra and bladder,including the position of the urethro-vesical junction(1.61 cm±1.03 cm vs 2.13 cm±0.71 cm),the position of the posterior bladder wall(4.13 cm±2.46 cm vs 5.23 cm±2.21 cm),the urethra angle(94.22°±35.62°vs 114.28°±35.55°),the length of the closed urethra(2.28 cm±0.90 cm vs 2.15 cm±0.65 cm),and bladder funneling(23.81%vs 45.61%),all the differences were statistically significant(P<0.05).The area under the curve(AUC)of multiple parameters MRD in the diagnosis of SUI was 0.73.The AUC in diagnosis of SUI by MRD combined with clinical history was 0.95.Conclusion POP combined with SUI has characteristic MRD signs.MRD technology can assist clinicians and improve the preoperative diagnosis rate of moderate and severe POP combined with SUI.